The blue-chip Dow Jones Industrial Average closed at a record high today as investors welcomed a subdued inflation report ...

U.S. stocks closed another record-setting week with a muted performance Friday, as hope built on Wall Street that the U.S. economy can manage the rare feat of suppressing high inflation without ...

The Dow Jones Industrial Average edged up to another record high while declines in tech stocks pulled other indexes lower.

A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...

The Dow jumped more than 400 points Friday to an all-time high after a benign inflation report cleared the way for the ...

British scientists have hailed the US approval of a new drug for schizophrenia, saying it “has the potential to change the ...

U.S. stock indexes are drifting around their records Friday as hopes hold that the economy can pull off the rare feat of ...

Cobenfy targets cholinergic receptors instead of the dopamine receptors long addressed in current schizophrenia drugs — a new treatment approach to the disease.

By way of two resoundingly consistent votes, members of an FDA advisory committee agreed that PD-1 inhibitors do not have a favorable risk/benefit profile for gastroesophageal cancers with low PD-L1 ...

An oral session Friday at the International Myeloma Society 21st Annual Meeting & Exposition offered updates for the TRIMM-2 ...

The U. S. Food and Drug Administration (FDA) has signed off on Cobenfy, the first revolutionary treatment for schizophrenia ...

U.S. equities were mixed at midday as the Federal Reserve's favored measure of inflation was lower than anticipated.